<DOC>
	<DOCNO>NCT02672865</DOCNO>
	<brief_summary>The purpose study determine safety tolerability adjuvant hyperthermic intraperitoneal chemotherapy ( HIPEC ) mitomycin cisplatin subject locally advanced gastric cancer undergo standard surgical resection . Subjects treat HIPEC use single dose mitomycin 15mg/m2 cisplatin 50mg/m2 41-42 C 90 minute , definitive surgical procedure gastric cancer . HIPEC perform resection anastomosis .</brief_summary>
	<brief_title>Adjuvant Hyperthermic Intraperitoneal Chemotherapy Locally Advanced Gastric Cancer</brief_title>
	<detailed_description>Treatment Plan : Patients undergo definitive resection gastric cancer meeting eligibility criterion treat HIPEC use single dose Mitomycin 15mg/m2 Cisplatin 50mg/m2 41-42 C 90 minute . HIPEC perform resection anastomosis . Both Cisplatin Mitomycin commercially available chemotherapeutic agent obtain market drug . Outcome Measures : Patients follow 90 day follow surgery postoperative complication record graded accord modify Clavien-Dindo classification . Schedule Follow Up : Trial-related patient assessment perform daily patient remain hospital postoperative care , postoperative clinic visit . The final postoperative clinic visit evaluation study outcome complication occur postoperative day 90 95 allow cumulative assessment patient 's perioperative complication , .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Fever</mesh_term>
	<criteria>1 . Patients aged 1875 biopsyproven gastric adenocarcinoma 2 . Tumor clinically stag T3 T4 and/or node stag clinically positive 3 . ECOG performance status &lt; 2 1 . Distant metastases 2 . Peritoneal carcinomatosis 3 . Synchronous malignancy 4 . Tumors gastroesophageal junction 5 . Recurrent gastric adenocarcinoma 6 . Creatinine &gt; /= 1.5 7 . Bilirubin &gt; /= 2 8 . INR &gt; /= 2 9 . Allergy drug include treatment plan 10 . Pregnancy 11 . Contraindication major surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>